Physician profile
Lawrence Engmann
NPI 1396814174
$28,799.72
in general payments reported to CMS, 2019-2025
5 companies · $12K in 2025
The $12K reported for 2025 was more than what 98% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $54.52 · 2021: $159 · 2022: $12K · 2023: $518 · 2024: $3,927 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $1,427 · Food and Beverage: $858 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,393.00 |
| Travel and Lodging | $1,426.82 |
| Food and Beverage | $858.44 |
| Education | $160.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $28,169.82 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $245.01 | 2021-2025 | Stripper |
| Organon LLC | $222.42 | 2021-2025 | Ganirelix Acetate, Pregnyl |
| Emd Serono, INC. | $94.90 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $67.57 | 2019-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Engmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.